Threshold Pharmaceuticals Company Profile (NASDAQ:THLD)

Analyst Ratings

Consensus Ratings for Threshold Pharmaceuticals (NASDAQ:THLD) (?)
Ratings Breakdown: 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $13.00 (2,445.03% upside)

Analysts' Ratings History for Threshold Pharmaceuticals (NASDAQ:THLD)
Show:
DateFirmActionRatingPrice TargetActions
12/7/2015Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Cantor FitzgeraldReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015MLV & Co.Set Price TargetBuy$14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/5/2014HC WainwrightInitiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Threshold Pharmaceuticals (NASDAQ:THLD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/29/2016        
5/5/2016Q1($0.02)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q4($0.11)$0.86ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q315($0.14)($0.09)$3.69 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q2($0.14)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015($0.14)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414($0.13)($0.12)$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q314($0.12)($0.15)$3.82 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2014($0.13)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014($0.10)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q413($0.10)($0.13)$3.58 million$3.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313($0.14)$0.02$3.15 million$3.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.09)($0.16)$2.80 million$2.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2012Q312($0.06)($0.06)$2.29 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Threshold Pharmaceuticals (NASDAQ:THLD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.15)($0.15)($0.15)
Q2 20161($0.12)($0.12)($0.12)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.12)($0.12)($0.12)
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.09)($0.09)($0.09)
Q3 20171($0.10)($0.10)($0.10)
Q4 20171($0.10)($0.10)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Threshold Pharmaceuticals (NASDAQ:THLD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Threshold Pharmaceuticals (NASDAQ:THLD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/18/2015Wilfred E JaegerDirectorBuy25,000$3.75$93,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Nipun DavarVPBuy3,000$2.99$8,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Hill Ventures SutterMajor ShareholderSell226,657$3.77$854,496.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Jeffrey W BirdDirectorSell238,520$3.77$899,220.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014David L AndersonMajor ShareholderSell13,988$4.01$56,091.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Wilfred JaegerDirectorSell96,356$4.86$468,290.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Wilfred JaegerDirectorSell424,956$4.87$2,069,535.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Wilfred JaegerDirectorSell723,900$4.88$3,532,632.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Wilfred E JaegerDirectorSell322,000$5.53$1,780,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Wilfred E JaegerDirectorSell178,000$5.51$980,780.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2013Wilfred E JaegerDirectorSell219,667$5.53$1,214,758.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Wilfred E JaegerDirectorSell2,000$5.50$11,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Wilfred E JaegerDirectorSell124,733$5.51$687,278.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Wilfred E JaegerDirectorSell153,600$5.48$841,728.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013David L AndersonMajor ShareholderSell266,542$5.72$1,524,620.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Jeffrey W BirdDirectorSell273,181$5.72$1,562,595.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Tillman PearceInsiderSell20,000$5.63$112,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Threshold Pharmaceuticals (NASDAQ:THLD)
DateHeadline
07/29/16 07:02 PMHC Stocks Reports: Eli Lilly and Co (NYSE:LLY), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - share market updates (press release)
07/28/16 10:04 AMHC Stocks Outlines: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Threshold Pharmaceuticals, Inc ... - share market updates (press release)
07/28/16 10:04 AMTime To Put On The Watch List? - Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Catalyst Biosciences, Inc ... - The Voice Registrar
07/28/16 10:04 AMHave a look at Analyst Actions: Mylan N.V. (NASDAQ:MYL) , Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Street Updates
07/28/16 10:04 AMHC Stocks Reports: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release)
07/26/16 07:16 PMThreshold Pharmaceuticals Inc. (THLD) Jumps 14.7% on July 26 - Equities.com
07/26/16 10:17 AMThreshold Pharmaceuticals, Inc. (THLD) Updated Price Targets ... - FTSE News
07/22/16 06:37 PMHC Stocks Outlines: Eli Lilly and Co (NYSE:LLY), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - share market updates (press release)
07/22/16 06:36 PMThreshold Pharmaceuticals Inc. (THLD) Drops 5.93% on July 21 - Equities.com
07/21/16 07:07 PMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 03:50 PMTHRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule -
07/20/16 09:42 AMHC Stocks Assessment: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Threshold Pharmaceuticals, Inc ... - share market updates (press release)
07/20/16 09:42 AMEquity Roundup: Stock Performance Focus on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Press Telegraph
07/19/16 07:46 AMNotable Intraday Movers: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Sumitomo Mitsui Financial Grp, Inc. (ADR ... - NYSE Journal (press release)
07/17/16 06:05 PMCan Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Surprise Analysts this Quarter? - Investor Newswire
07/15/16 05:47 PMThreshold Pharmaceuticals Inc. (THLD) Drops 9.75% on July 13 - Equities.com
07/13/16 09:40 AMThreshold Pharmaceuticals Incorporated (NASDAQ:THLD) Shorted Shares Increased By 10.55% - Consumer Eagle
07/08/16 09:38 AMBrokers Issue Average Price Target Of 13.88 On Threshold Pharmaceuticals, Inc. (THLD) - Fiscal Standard
07/07/16 09:32 AMThreshold Pharmaceuticals Inc. (THLD) Drops 11.43% on July 05 - Equities.com
07/06/16 07:13 PMNoticeable Analyst's ideas: Astrazeneca PLC (NYSE:AZN) , Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - Street Updates
07/06/16 07:13 PMEye Catching Stock: Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - News Oracle
07/06/16 08:40 AMNoteworthy HC Stocks: Opko Health Inc. (NASDAQ:OPK), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) - share market updates (press release)
07/06/16 08:40 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 10.17% on July 04 - Equities.com
07/02/16 06:13 PMAnalyst Recommendations Watch: Threshold Pharmaceuticals Inc. (NASDAQ:THLD) - News Oracle
07/01/16 09:25 AMAnalysts Update on Stocks: OraSure Technologies, Inc. (NASDAQ:OSUR) , Threshold Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
07/01/16 09:25 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 9.01% on June 30 - Equities.com
06/30/16 09:32 AMHC Stocks Outlines: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) - share market updates (press release)
06/30/16 09:32 AMTake a look at Analyst Tips: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Baxter International Inc. (NYSE:BAX) - Street Updates
06/28/16 06:41 PMThreshold Pharmaceuticals Incorporated (NASDAQ:THLD) Short Interest Increased By 10.55% - Press Telegraph
06/28/16 09:16 AMThreshold Pharmaceuticals, Inc. (THLD) Updated Price Targets - FTSE News
06/27/16 04:12 PMTHRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/26/16 08:52 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 7.14% on June 23 - Equities.com
06/24/16 09:20 AMRecently Issued Stock Ratings For Threshold Pharmaceuticals, Inc. (THLD) - Fiscal Standard
06/23/16 07:31 PMThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) Earnings Glance and Target Price Review - Engelwood Daily
06/15/16 06:40 PMHC Stocks in Top Row: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Intercept Pharmaceuticals Inc (NASDAQ:ICPT) - share market updates (press release)
06/13/16 09:45 AMThreshold Pharmaceuticals Inc. (NASDAQ:THLD) decreased -4.00%: Weatherford International plc (NYSE:WFT ... - KC Register
06/09/16 07:18 PMEarnings Expectations of the Stocks: Francesca's Holdings Corporation (FRAN), Threshold Pharmaceuticals Inc. (THLD) - Beacon Chronicle
06/08/16 09:54 AMStocks Earnings Analysis Report: Threshold Pharmaceuticals Inc. (NASDAQ:THLD), Entergy Corporation (NYSE:ETR) - Beacon Chronicle
06/08/16 09:54 AMTHRESHOLD PHARMACEUTICALS INC. (NASDAQ:THLD) Financial Condition Compared to S&P 500 - CML News
06/08/16 09:54 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 8.43% on June 06 - Equities.com
06/07/16 07:03 PMComprehensive Analysis of: Tsakos Energy Navigation Limited (NYSE:TNP), Threshold Pharmaceuticals Inc ... - Beacon Chronicle
06/07/16 09:41 AMTraders Targeted Movers: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Alkermes plc (NASDAQ:ALKS) - Street Updates
06/06/16 07:48 AMThreshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO Annual Meeting - [at noodls] - June 6, 2016 Presentation of additional subset data from Phase 3 MAESTRO trial of evofosfamide in pancreatic cancer demonstrates meaningful improvement in overall survival in patients from Asia; risk of ...
06/06/16 07:34 AM8:34 am Threshold Pharma highlights multiple presentations at ASCO; Presentation of additional subset data from Phase 3 MAESTRO trial of evofosfamide in pancreatic cancer demonstrates meaningful improvement in overall survival in patients f -
06/04/16 09:55 AMStocks Update: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) , Acceleron Pharma Inc. (NASDAQ:XLRN) - Is stories
06/03/16 09:48 AMBroker Watchlist: Threshold Pharmaceuticals, Inc. (THLD) - Share Trading News
06/01/16 09:47 AMThreshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 30 - Equities.com - Threshold Pharmaceuticals Inc. (THLD) Jumps 7.17% on May 30Equities.comThreshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Monday May 30 as the stock popped 7.17% to $0.48, representing a gain of $0.0321 per share. Some 571,228 shares traded hands on 880 trades, compared with ...and more »
06/01/16 07:33 AMThreshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference - [at noodls] - June 1, 2016 Company Presentation Scheduled for June 7, 2016 at 3:30 p.m. ET SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) today announced ...
05/31/16 09:53 AMTraded Price Fluctuations to Observe: Cerus Corporation (NASDAQ:CERS) , Threshold Pharmaceuticals, Inc ... - Street Updates - Traded Price Fluctuations to Observe: Cerus Corporation (NASDAQ:CERS) , Threshold Pharmaceuticals, Inc ...Street UpdatesThreshold Pharmaceuticals, Inc. (NASDAQ:THLD) after beginning at $0.4600, closed at $0.4795 by building up +7.1748% in recent trading session. Most recent session's volume of 571.23 thousand shares lower than its average volume of 1.1 million shares.
05/30/16 10:23 PMNext Weeks Broker Price Targets For Threshold Pharmaceuticals, Inc. (THLD) - Share Trading News - Next Weeks Broker Price Targets For Threshold Pharmaceuticals, Inc. (THLD)Share Trading NewsThreshold Pharmaceuticals, Inc. has a 50 day moving average of 0.41 and a 200 day moving average of 0.88. The stock's market capitalization is 34.29M, it has a 52-week low of 0.21 and a 52-week high of 5.28. The share price of the company (THLD) was ...Threshold Pharmaceuticals Incorporated (NASDAQ:THLD) Sellers Increased By 0.97% Their ShortsFranklin Independentall 2 news articles »

Social

About Threshold Pharmaceuticals

Threshold Pharmaceuticals logoThreshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. Evofosfamide is designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not in healthy tissues. Tarloxotinib is under investigation in two Phase II proof-of-concept trials: one for the treatment of patients with mutant EGFR-positive, T790M-negative advanced NSCLC progressing on an EGFR TKI, and the other for patients with recurrent or metastatic squamous cell carcinomas of the head and neck. [18F]-HX4 is an investigational Positron Emission Tomography imaging agent for hypoxia to identify and quantify the degree of hypoxia in tumors in vivo.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: THLD
  • CUSIP: 88580720
Key Metrics:
  • Previous Close: $0.52
  • 50 Day Moving Average: $0.5131
  • 200 Day Moving Average: $0.4181
  • P/E Ratio: 0.8792
  • P/E Growth: 0.0000
  • Market Cap: $36.53M
  • Beta: 3.79
  • Current Year EPS Consensus Estimate: $-0.45 EPS
  • Next Year EPS Consensus Estimate: $-0.42 EPS
Additional Links:
Threshold Pharmaceuticals (NASDAQ:THLD) Chart for Saturday, July, 30, 2016